<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Association between Helicobacter pylori infection and gastrointestinal malignancy
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Association between Helicobacter pylori infection and gastrointestinal malignancy
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Association between Helicobacter pylori infection and gastrointestinal malignancy
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            J Thomas Lamont, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Mark Feldman, MD, MACP, AGAF, FACG
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Shilpa Grover, MD, MPH, AGAF
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 23, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Since the discovery of
         <em>
          Helicobacter pylori
         </em>
         in the 1980s, much has been learned about this gram-negative spiral bacteria and its associated disease states. In 1994, the National Institutes of Health Consensus Conference recognized
         <em>
          H. pylori
         </em>
         as a cause of gastric and duodenal ulcers. Later that year, the International Agency for Research on Cancer declared
         <em>
          H. pylori
         </em>
         to be a group I human carcinogen for gastric adenocarcinoma [
         <a href="#rid1">
          1
         </a>
         ]. There is also evidence that
         <em>
          H. pylori
         </em>
         infection is a risk factor for gastric mucosa-associated lymphomas (MALT lymphomas). (See
         <a class="medical medical_review" href="/z/d/html/4743.html" rel="external">
          "Clinical presentation and diagnosis of primary gastrointestinal lymphomas"
         </a>
         .)
        </p>
        <p>
         Despite these clear associations, there is marked individual variability in the outcomes of
         <em>
          H. pylori
         </em>
         infection, with most patients having a non-neoplastic rather than neoplastic process.
         <em>
          H. pylori
         </em>
         infection is associated with a complex interaction between genetic, environmental, and bacterial factors, which potentially explains the different outcomes possible following infection. Until these factors are better defined and their interactions better understood, practitioners should limit testing for and treating
         <em>
          H. pylori
         </em>
         to those situations where there is evidence to support a clinical benefit.
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          GASTRIC CANCER
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastric cancer is one of the most common causes of cancer-related death in the world [
         <a href="#rid2">
          2
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/2616.html" rel="external">
          "Epidemiology of gastric cancer"
         </a>
         ). Gastric cancers can be categorized by site of occurrence: gastroesophageal junction, proximal stomach, and distal stomach (body and antrum). In the 1930s in the United States, distal cancers were the most common. Over the subsequent 70 years, the incidence of gastric cancer has fallen primarily due to a reduction in distal cancers. In comparison, an increase in the incidence of gastroesophageal junction and proximal cancers has been noted during the past several decades [
         <a href="#rid3">
          3,4
         </a>
         ]. These observations suggest that gastroesophageal and proximal gastric cancers share a common pathogenesis, which is distinct from that of distal cancers [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
         Adenocarcinomas, which accounts for more than 90 percent of tumors arising in the stomach, are of two distinct morphologic types: intestinal-type and diffuse. A sequence of steps with phenotypic changes in the gastric mucosa has been hypothesized as a model for carcinogenesis of intestinal type adenocarcinomas: superficial gastritis; chronic atrophic gastritis; intestinal metaplasia  (
         <a class="graphic graphic_picture graphicRef64199" href="/z/d/graphic/64199.html" rel="external">
          picture 1
         </a>
         ); dysplasia; and finally carcinoma  (
         <a class="graphic graphic_algorithm graphicRef73741" href="/z/d/graphic/73741.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid6">
          6
         </a>
         ]. No similar sequence has been described for the diffuse type. (See
         <a class="medical medical_review" href="/z/d/html/119517.html" rel="external">
          "Gastric cancer: Pathology and molecular pathogenesis"
         </a>
         .)
        </p>
        <p>
         <em>
          H. pylori
         </em>
         can cause chronic active gastritis and atrophic gastritis, early steps in the carcinogenesis sequence [
         <a href="#rid7">
          7,8
         </a>
         ]. In animal models,
         <em>
          H. pylori
         </em>
         infection has induced gastric adenocarcinoma [
         <a href="#rid9">
          9
         </a>
         ]. Furthermore, a number of studies in humans have demonstrated a clear association between
         <em>
          H. pylori
         </em>
         infection and gastric adenocarcinoma [
         <a href="#rid10">
          10-12
         </a>
         ]. The link has been demonstrated in both the intestinal and diffuse subtypes of gastric cancer [
         <a href="#rid10">
          10,13
         </a>
         ].
        </p>
        <p>
         The relationship between
         <em>
          H. pylori
         </em>
         infection and gastric carcinogenesis in humans can be illustrated by the following observations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          H. pylori
         </em>
         has been identified histologically in the uninvolved mucosa from stomachs harboring cancers or precancerous changes (eg, atrophic gastritis with or without accompanying intestinal metaplasia) [
         <a href="#rid14">
          14,15
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Epidemiologic studies demonstrate a strong correlation between
         <em>
          H. pylori
         </em>
         seropositivity and gastric cancer. As an example, the EUROGAST study of 17 populations from 13 different countries (11 European countries, the United States, and Japan) found a sixfold increased risk of gastric cancer in
         <em>
          H. pylori
         </em>
         -infected populations compared with uninfected populations [
         <a href="#rid16">
          16
         </a>
         ]. Similar findings have been noted in nested-case control studies in which the stored serum of patients with known gastric adenocarcinoma and that of matched controls were tested for
         <em>
          H. pylori
         </em>
         IgG antibody.
         <em>
          H. pylori
         </em>
         infection was associated with odds ratios ranging from 2.8 to 49 and attributable risks of 46 to 63 percent [
         <a href="#rid12">
          12,17-20
         </a>
         ]. In a nested case control study of Japanese Americans living in Hawaii, for example,
         <em>
          H. pylori
         </em>
         seropositivity was present in 94 percent of patients with gastric cancer compared with 76 percent of matched controls; the odds ratio was 6.0 [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Two meta-analyses of cohort and case control studies examining the relationship between
         <em>
          H. pylori
         </em>
         seropositivity and gastric cancer found that
         <em>
          H. pylori
         </em>
         infection was associated with a twofold increased risk for developing gastric adenocarcinoma [
         <a href="#rid10">
          10,11
         </a>
         ]. The relative risk for gastric cancer was greatest for younger patients (9.29 at age less than 29) in whom the absolute risk is still quite low [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         One of the largest prospective studies addressing
         <em>
          H. pylori
         </em>
         and cancer risk included 1526 Japanese patients of whom 1246 had
         <em>
          H. pylori
         </em>
         infection [
         <a href="#rid21">
          21
         </a>
         ]. Patients underwent endoscopy with biopsy at enrollment and then between one and three years after enrollment. During a mean follow-up of 7.8 years, 36 patients developed gastric cancer (2.9 percent), all of whom were
         <em>
          H. pylori
         </em>
         infected. No uninfected patient developed cancer.
        </p>
        <p>
         The International Agency for Research on Cancer estimates that 36 and 47 percent of all gastric cancers in developed and developing countries, respectively, are solely attributable to
         <em>
          H. pylori
         </em>
         infection. This accounts for almost 350,000 gastric cancers annually worldwide. One report indicated that of the 12.7 million new cancers occurring in 2008, the population attributable fraction due to infections was over 16 percent for
         <em>
          H
         </em>
         .
         <em>
          pylori
         </em>
         [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p>
         Despite the clear association between
         <em>
          H. pylori
         </em>
         and gastric adenocarcinomas, only a minority of infected individuals will develop gastric cancer. It is thought that modulation of the effects of infection by external, mostly environmental factors (and possibly strain differences in
         <em>
          H. pylori
         </em>
         , see below) influence whether infection results in a neoplastic or non-neoplastic process.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Role of H. pylori in carcinogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several hypotheses have been proposed to explain the role of
         <em>
          H. pylori
         </em>
         in carcinogenesis, although the exact mechanism is incompletely understood [
         <a href="#rid23">
          23
         </a>
         ]. At present, it is believed that bacterial properties, host response, and environmental factors all play a role.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          H. pylori strain differences
         </span>
         <span class="headingEndMark">
          —
         </span>
         The strain of
         <em>
          H. pylori
         </em>
         also may be a determinant of its potential to cause cancer or ulcer disease. (See
         <a class="medical medical_review" href="/z/d/html/15.html" rel="external">
          "Pathophysiology of and immune response to Helicobacter pylori infection", section on 'Bacterial strain differences'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26856593">
         <span class="h2">
          Host immune responses
         </span>
         <span class="headingEndMark">
          —
         </span>
         Host genetics that regulate the immune response and mucosal events that result from infection play important roles in gastric cancer development in chronically infected individuals.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h3">
          Cytokine polymorphisms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Certain polymorphisms in IL-1 beta and other cytokines may confer an increased susceptibility to non-cardia gastric adenocarcinoma caused by
         <em>
          H. pylori
         </em>
         by inducing a hypochlorhydric and atrophic response to
         <em>
          H. pylori
         </em>
         infection [
         <a href="#rid24">
          24-29
         </a>
         ]. An illustrative study compared IL-1 beta polymorphisms in 393 patients with gastric cancer with 430 controls [
         <a href="#rid24">
          24
         </a>
         ]. Two specific polymorphisms (IL-1B-31T and IL-1RN*2) were associated with low acid secretion and gastric atrophy. The authors concluded that 38 percent of
         <em>
          H. pylori
         </em>
         -related gastric cancer could be attributed to the presence of these alleles. IL-1 beta, a potent inhibitor of gastric acid secretion, is upregulated by the presence of H. pylori.
        </p>
        <p>
         A similar report compared polymorphisms in genes for several cytokines in patients with a variety of gastric and esophageal malignancies with a control population [
         <a href="#rid25">
          25
         </a>
         ]. Proinflammatory genotypes of tumor necrosis factor alpha and IL-10 were associated with more than a doubling of the risk of non-cardia gastric cancer. Carriage of multiple proinflammatory polymorphisms of IL-1 beta, IL-1 receptor antagonist, tumor necrosis factor A, and IL-10 conferred even greater risk (OR 2.8 for one, 5.4 for two, and 27.3 for more than three). By contrast, these polymorphisms were not associated with an increased risk of esophageal or gastric cardia cancers.
        </p>
        <p>
         These data suggest that gene polymorphisms influence cytokine expression, gastric inflammation, and risk for development of precancerous lesions in those infected with
         <em>
          H. pylori
         </em>
         . Infection with certain virulent bacterial strain types augments inflammation and cancer risk, supporting a complex interaction between host and bacterial in the development of GI pathology [
         <a href="#rid30">
          30
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2617.html" rel="external">
          "Risk factors for gastric cancer", section on 'Genetic polymorphisms'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26856587">
         <span class="h3">
          Neutrophil activation
         </span>
         <span class="headingEndMark">
          —
         </span>
         One hypothesis has been demonstrated in vitro. CD11a/CD18- and CD11b/CD18-neutrophils, induced by
         <em>
          H. pylori
         </em>
         infection, interact with intercellular adhesion molecule-1 (ICAM-1), resulting in the migration of neutrophils to the site of infection and adhesion to the surface epithelium. The recruited neutrophils then produce inducible nitric oxide synthase and release nitric oxide and reactive oxygen metabolites, such as superoxide and hydroxyl ions, which in turn damage DNA. This is followed by mutation and malignant transformation. (See
         <a class="medical medical_review" href="/z/d/html/119517.html" rel="external">
          "Gastric cancer: Pathology and molecular pathogenesis", section on 'Helicobacter pylori'
         </a>
         .)
         <em>
          H. pylori
         </em>
         induces oxidative stress in epithelial cells [
         <a href="#rid31">
          31
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H26856606">
         <span class="h2">
          Epithelial responses
         </span>
         <span class="headingEndMark">
          —
         </span>
         <em>
          H. pylori
         </em>
         and the immune response induce altered rates of gastric epithelial cell growth and death, which involve various signaling pathways leading to apoptosis, proliferation, differentiation, and autophagy.
        </p>
        <p class="headingAnchor" id="H26856178">
         <span class="h3">
          Apoptotic pathways
         </span>
         <span class="headingEndMark">
          —
         </span>
         Two important processes in carcinogenesis are apoptosis (programmed cell death) and hyperproliferation [
         <a href="#rid32">
          32
         </a>
         ]. Following severe DNA damage, apoptosis occurs as a protective mechanism to prevent replication of mutated DNA. Atrophic gastritis with destruction and loss of the glands could be the result of apoptosis. This hypothesis is supported by the finding of an increased rate of antral apoptosis in
         <em>
          H. pylori
         </em>
         -infected subjects [
         <a href="#rid33">
          33,34
         </a>
         ], which returns to normal following eradication therapy [
         <a href="#rid33">
          33
         </a>
         ]. The mechanism by which
         <em>
          H. pylori
         </em>
         induces apoptosis is unclear. One study suggested that the organism causes apoptosis by both direct and indirect mechanisms [
         <a href="#rid35">
          35
         </a>
         ]. In the latter circumstance,
         <em>
          H. pylori
         </em>
         appears to sensitize epithelial cells for apoptosis which is induced by proinflammatory stimuli (eg, tumor necrosis factor alpha).
         <em>
          H. pylori
         </em>
         enhances expression of the Fas receptor on gastric epithelial cells and may mediate apoptosis through signaling mechanisms related to the Fas death receptor [
         <a href="#rid36">
          36
         </a>
         ]. Proliferating cells may be resistant to apoptosis. This would upset the balance between cell growth and death, leading to hyperproliferation and the promotion of neoplasia [
         <a href="#rid37">
          37
         </a>
         ]. There is evidence of an increased amount of the anti-apoptosis protein, Bcl-2, in the setting of gastric dysplasia [
         <a href="#rid38">
          38
         </a>
         ]. Other reports have found that apoptosis may be due to plasminogen activator inhibitor (PAI)-2, the expression of which is increased by
         <em>
          H. pylori
         </em>
         . PAI-2 is increased in gastric cancer [
         <a href="#rid39">
          39
         </a>
         ]. An uncoupling of epithelial proliferation and apoptosis may be a strain-dependent phenomenon. Hyperproliferation has been seen in CagA-infected patients in whom apoptosis is not increased [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H26856599">
         <span class="h3">
          Cell signaling events
         </span>
         <span class="headingEndMark">
          —
         </span>
         One report indicated that c-Src and c-Abl kinases sequentially phosphorylate CagA [
         <a href="#rid41">
          41
         </a>
         ]. The two phosphorylation events need not occur on the same CagA molecule but are both required for the biological effects of CagA. Another study demonstrated that vacuolating cytotoxin and variants in Atg16L1 disrupt autophagy and promote
         <em>
          H. pylori
         </em>
         infection in humans. As autophagy protects against infection with
         <em>
          H. pylori
         </em>
         , this could contribute to inflammation and eventual carcinogenesis [
         <a href="#rid42">
          42
         </a>
         ]. A potentially important observation is that the source of gastric cancer may not be from gastric epithelial cells themselves but rather from bone marrow-derived cells that differentiate into gastric epithelial cells in the presence of
         <em>
          H. pylori
         </em>
         [
         <a href="#rid43">
          43
         </a>
         ]. If this observation is confirmed, it would have significant implications for the treatment of
         <em>
          H. pylori
         </em>
         -associated gastric cancer as well as other epithelial cancers associated with chronic inflammation. (See
         <a class="medical medical_review" href="/z/d/html/119517.html" rel="external">
          "Gastric cancer: Pathology and molecular pathogenesis", section on 'The preneoplastic cascade'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26856613">
         <span class="h2">
          Environmental factors
         </span>
        </p>
        <p class="headingAnchor" id="H26856621">
         <span class="h3">
          Interaction between H. pylori and diet
         </span>
         <span class="headingEndMark">
          —
         </span>
         The consumption of salted food appears to increase the possibility of persistent infection with
         <em>
          H. pylori
         </em>
         infection [
         <a href="#rid44">
          44,45
         </a>
         ]. In addition, a synergistic interaction between
         <em>
          H. pylori
         </em>
         infection and salted food intake to increase the risk of gastric cancer has also been reported in case control studies [
         <a href="#rid46">
          46,47
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/16.html" rel="external">
          "Bacteriology and epidemiology of Helicobacter pylori infection"
         </a>
         ). Animal studies also suggest that
         <em>
          H. pylori
         </em>
         infection and high-salt intake act synergistically to promote the development of gastric cancer [
         <a href="#rid48">
          48
         </a>
         ]. In one study in Mongolian gerbils, expression of the proinflammatory mediators, inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2), were significantly upregulated. Both iNOS and COX-2 overexpression have been demonstrated in gastric cancer [
         <a href="#rid49">
          49-52
         </a>
         ]. On the other hand, there was no significant effect on these mediators in noninfected animals [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         Studies suggest that
         <em>
          H. pylori
         </em>
         might affect other dietary associations with gastric cancer [
         <a href="#rid54">
          54,55
         </a>
         ]. The potential protective effect of dietary antioxidants such as vitamins C and E and
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          beta-carotene
         </a>
         seems to be stronger in those infected by
         <em>
          H. pylori
         </em>
         , even though results are inconsistent. The risk of gastric cancer associated with red meat, processed meat, or endogenous formation of nitrosamines appears to be observed only in patients infected with
         <em>
          H. pylori
         </em>
         . A reported genetic polymorphism found to be protective against
         <em>
          H. pylori
         </em>
         carcinogenesis in mice, vitamin D3 upregulated protein 1, suggests a possible link between vitamin D deficiency and propensity for
         <em>
          H. pylori
         </em>
         infection to progress into gastric cancer in humans [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H26856628">
         <span class="h3">
          Hypochlorhydria and ascorbic acid
         </span>
         <span class="headingEndMark">
          —
         </span>
         Another hypothesis involves a role for hypochlorhydria and ascorbic acid  (
         <a class="graphic graphic_algorithm graphicRef73741" href="/z/d/graphic/73741.html" rel="external">
          algorithm 1
         </a>
         ) [
         <a href="#rid6">
          6
         </a>
         ]. In the sequence of carcinogenesis from atrophic gastritis to metaplasia, loss of the acid-secreting parietal cells results in an elevated gastric pH. Nitrate-reducing bacteria proliferate in the stomach and, at the high pH, nitrite is formed, which can interact with other nitrogen-containing compounds and with carcinogens. Ascorbic acid may block this nitrosation reaction by scavenging nitrates and free radicals [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p>
         The following observations suggest a role for the relative lack of ascorbic acid in the pathogenesis of gastric cancer:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The level of ascorbic acid in gastric juice is markedly reduced in the setting of chronic gastritis, elevated gastric pH, and
         <em>
          H. pylori
         </em>
         infection; this may be due to impaired secretion of ascorbic acid due to the chronic gastritis [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with intestinal metaplasia have lower serum levels of ascorbic acid compared with controls [
         <a href="#rid58">
          58
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Low levels of dietary ascorbic acid can lead to progression of precancerous lesions to dysplasia and cancer in high-risk individuals [
         <a href="#rid59">
          59
         </a>
         ]. Ascorbic acid ingestion was associated with a decreased risk of gastric cancer in case-control studies [
         <a href="#rid60">
          60,61
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3007203">
         <span class="h3">
          Hemoglobin A1c
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other host factors may contribute to the development of gastric cancer in
         <em>
          H. pylori
         </em>
         -infected individuals. A study of 2603 Japanese subjects aged ≥40 years were stratified into four groups according to baseline hemoglobin A1c (HbA1c) levels (≤4.9 percent, 5.0 to 5.9 percent, 6.0 to 6.9 percent, and ≥7.0 percent) and followed up prospectively for 14 years [
         <a href="#rid62">
          62
         </a>
         ]. During the follow-up, 97 subjects developed gastric cancer. The age- and sex-adjusted incidence of gastric cancer significantly increased in the two higher HbA1c level groups. This association remained substantially unchanged even after adjusting for the confounding factors including
         <em>
          H. pylori
         </em>
         seropositivity. Among subjects who had both high HbA1c levels (≥6.0 percent) and
         <em>
          H. pylori
         </em>
         infection, the risk of gastric cancer was dramatically elevated. The mechanism whereby elevated blood sugar enhances the risk of gastric cancer is unclear but the risk of other cancers has been shown to be increased in those with diabetes mellitus.
        </p>
        <p class="headingAnchor" id="H26856634">
         <span class="h3">
          Obesity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Obesity has been reported to be associated with gastric cardia adenocarcinoma [
         <a href="#rid63">
          63,64
         </a>
         ]. A mechanism explaining this association has not been established but it may be related to
         <em>
          H. pylori
         </em>
         infection as there is an apparent increased prevalence of
         <em>
          H. pylori
         </em>
         infection in patients with obesity. Another possibility is that hyperglycemia increases the risk of developing gastric cancer [
         <a href="#rid62">
          62
         </a>
         ]. Collectively, these studies lead to the possibility that eradication of
         <em>
          H. pylori
         </em>
         in conjunction with weight loss or better glycemic control might decrease risk of gastric cancer.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Importance of other factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Gastric carcinogenesis cannot be explained by
         <em>
          H. pylori
         </em>
         infection alone as illustrated by the following observations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Only a small fraction of
         <em>
          H. pylori
         </em>
         -infected individuals develop cancer.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The incidence of gastric cancer varies regionally despite similar prevalence of
         <em>
          H. pylori
         </em>
         worldwide [
         <a href="#rid5">
          5,65
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The gastric cancer risk is not increased in patients with
         <em>
          H. pylori
         </em>
         -related duodenal ulcer disease. To the contrary, in a study from Sweden evaluating the incidence of gastric cancer in patients previously hospitalized for gastric or duodenal ulcer, the incidence was significantly
         <strong>
          decreased
         </strong>
         in the group with duodenal ulcer (standardized incidence ratio 0.6 versus 1.8 in those with gastric ulcer) [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The explanation for this protective feature of
         <em>
          H. pylori
         </em>
         -induced duodenal ulcer is unclear. One theory is that atrophic gastritis, which is an early step in gastric carcinogenesis [
         <a href="#rid67">
          67
         </a>
         ], occurs with
         <em>
          H. pylori
         </em>
         -related gastric ulcers but not duodenal ulcers. Host factors may influence the susceptibility to
         <em>
          H. pylori
         </em>
         -induced gastric atrophy. Support for the relationship between atrophic gastritis and
         <em>
          H. pylori
         </em>
         infection was derived from a study which found that an HLA-DQA1 allele appeared to contribute to resistance against
         <em>
          H. pylori
         </em>
         -associated gastric atrophy and gastric adenocarcinoma [
         <a href="#rid68">
          68
         </a>
         ].
        </p>
        <p>
         Strain differences may also provide some explanation. As noted above, infection with
         <em>
          H. pylori
         </em>
         that contain a duodenal ulcer promoting gene, DupA, appears to lower the risk for gastric cancer [
         <a href="#rid69">
          69
         </a>
         ]. Another hypothesis is that duodenal ulcer may be associated with an increased level of ascorbic acid [
         <a href="#rid70">
          70
         </a>
         ], which may protect against subsequent development of gastric cancer.
        </p>
        <p>
         Finally, as noted above, cytokine polymorphisms associated with cancer result in more diffuse gastritis and low acid secretion, gastric histology, and physiology unusual in duodenal ulcer patients.
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Role of family history
         </span>
         <span class="headingEndMark">
          —
         </span>
         A family history has been associated with a 1.5- to 3-fold increased risk of gastric cancer [
         <a href="#rid71">
          71,72
         </a>
         ]. Whether this reflects clustering of
         <em>
          H. pylori
         </em>
         within families with gastric cancer is uncertain. A case control study suggested that the two risks were independent [
         <a href="#rid73">
          73
         </a>
         ]. Relatives of patients with gastric cancer are more likely to be infected by
         <em>
          H. pylori
         </em>
         than unrelated controls. Infected relatives are also more likely to have low gastric acid secretion, a known marker/risk factor for gastric cancer [
         <a href="#rid74">
          74
         </a>
         ]. As noted above, this observation may be explained by hereditary differences in inflammatory cytokine polymorphisms that determine a host's acid secretory profile and the degree and distribution of gastric inflammation that results from
         <em>
          H. pylori
         </em>
         infection. (See
         <a class="medical medical_review" href="/z/d/html/2617.html" rel="external">
          "Risk factors for gastric cancer", section on 'Importance of Helicobacter pylori infection'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Does treatment reduce risk of gastric cancer?
         </span>
         <span class="headingEndMark">
          —
         </span>
         Eradication of
         <em>
          H. pylori
         </em>
         appears to reduce the risk of gastric cancer [
         <a href="#rid75">
          75-77
         </a>
         ]. The magnitude of reduction varies by the baseline incidence of gastric cancer, but is seen even in populations with low gastric cancer incidence. A meta-analysis of 27 studies included 48606
         <em>
          H. pylori
         </em>
         infected individuals with 715 incident gastric cancers [
         <a href="#rid76">
          76
         </a>
         ]. Individuals with eradication of
         <em>
          H. pylori
         </em>
         had a lower incidence of gastric cancer as compared with those who did not receive eradication therapy (pooled incidence rate ratio 0.53; 95% CI 0.44-0.64). As compared with individuals in the lowest tertile of baseline cancer incidence, those in the intermediate and highest tertile of cancer incidence had a greater reduction in gastric cancer incidence rate with
         <em>
          H. pylori
         </em>
         eradication (incidence rate ratio 44 and 38 percent, respectively). The magnitude of benefit was not significantly different between asymptomatic individuals and those who had undergone endoscopic resection of gastric cancer. (See
         <a class="medical medical_review" href="/z/d/html/16858.html" rel="external">
          "Early gastric cancer: Treatment, natural history, and prognosis"
         </a>
         .)
        </p>
        <p>
         Even if treatment does reduce the gastric cancer risk, difficulties with screening for
         <em>
          H. pylori
         </em>
         and treatment arise. The cost of screening and treating would be large given the worldwide prevalence of
         <em>
          H. pylori
         </em>
         infection. Nevertheless, one study that economically modeled the cost of screening per year of life saved estimated that, in selected populations such as Japanese American, serologic screening for
         <em>
          H. pylori
         </em>
         beginning at age 50 was more beneficial than breast cancer screening [
         <a href="#rid78">
          78
         </a>
         ]. Another cost-effectiveness analysis concluded that screening and treatment could be cost-effective if the cancer risk following eradication could be restored to that of a population that had never been infected with
         <em>
          H. pylori
         </em>
         [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p>
         A number of major medical organizations have issued guidelines related to
         <em>
          H. pylori
         </em>
         screening and eradication in high-risk populations. As examples, Asian-Pacific guidelines and European guidelines support population-based screening in high-risk settings [
         <a href="#rid80">
          80,81
         </a>
         ]. Screening for gastric cancer is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2618.html" rel="external">
          "Gastric cancer screening"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          GASTRIC LYMPHOMA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Primary gastric lymphoma accounts for 3 percent of gastric neoplasms and 10 percent of lymphomas [
         <a href="#rid82">
          82
         </a>
         ]. The stomach is the most common extranodal site of lymphoma. Lymphoma can arise from lymph nodes or mucosal areas; the latter is referred to as a mucosa (gut)-associated lymphoid tissue tumor (MALToma, MALT-type lymphoma, or MALT lymphoma, now called extranodal marginal zone B-cell lymphoma of MALT type in the REAL classification), of which the stomach is the most common site  (
         <a class="graphic graphic_picture graphicRef68386 graphicRef59651" href="/z/d/graphic/68386.html" rel="external">
          picture 2A-B
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/4731.html" rel="external">
          "Splenic marginal zone lymphoma"
         </a>
         .)
        </p>
        <p>
         Presenting symptoms of gastric lymphoma include epigastric pain (which is the most common), weight loss, anorexia, vomiting, melena, hematemesis, back pain, and nausea. The diagnosis is based upon histologic criteria and the presence of B-cell markers by immunocytochemistry. Histology shows lymphoepithelial changes, polymorphic cellular content, centrocyte like cells, and reactive germinal centers. High-grade lymphoma (eg, diffuse large B-cell lymphoma) is distinguished from low-grade disease when the number of large blast cells exceeds 20 percent [
         <a href="#rid83">
          83
         </a>
         ].
        </p>
        <p>
         The normal stomach does not contain significant lymphoid tissue [
         <a href="#rid84">
          84
         </a>
         ]. However,
         <em>
          H. pylori
         </em>
         -induced gastritis leads to an aggregation of CD4+ lymphocytes and B cells in the gastric lamina propria. Antigen presentation occurs followed by T cell activation, B cell proliferation, and lymphoid follicle formation. The gastric follicle resembles those seen in the ileum in Peyer's patches [
         <a href="#rid85">
          85
         </a>
         ]. A follicle is characterized by a center consisting of centroblasts and centrocytes. The center is surrounded by a B cell zone referred to as a mantle. The mantle is enclosed by a marginal zone, which is also comprised of B cells.
        </p>
        <p>
         A hypothesis has been proposed to describe the development of gastric B-cell lymphoma of marginal zone type (previously called low-grade MALToma). The antigen-presenting cell interacts with a CD4+ T-cell. The activated T-cell then binds to a B-cell with an aberrant ability for unsuppressed proliferation. A population of centrocyte-like B-cells arise to form the marginal zone, thereby representing low-grade lymphoma [
         <a href="#rid85">
          85,86
         </a>
         ]. This hypothesis was supported in a report of two patients with gastric MALToma who had a previous gastric biopsy several years before the onset of lymphoma [
         <a href="#rid87">
          87
         </a>
         ]. The lymphomas were shown to arise from a B cell clone at the site of chronic gastritis.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          H. pylori infection and MALToma
         </span>
         <span class="headingEndMark">
          —
         </span>
         Multiple studies have demonstrated an association between
         <em>
          H. pylori
         </em>
         infection and MALToma, and have begun to elucidate the mechanisms underlying this association [
         <a href="#rid88">
          88-94
         </a>
         ]. As with gastric cancer, the development of MALToma may be related to specific
         <em>
          H. pylori
         </em>
         strains expressing the CagA protein. In one report, for example, serum IgG antibody to CagA was much more common in patients with MALToma than an
         <em>
          H. pylori
         </em>
         -infected control group (95 versus 67 percent) [
         <a href="#rid90">
          90
         </a>
         ]. It is also possible that other species of Helicobacter are involved in the development of gastric MALT lymphomas. As an example, an association with
         <em>
          H
         </em>
         .
         <em>
          heilmannii
         </em>
         has been described [
         <a href="#rid93">
          93,95
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Efficacy of anti-H. pylori therapy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The most dramatic evidence supporting a pathogenetic role for
         <em>
          H. pylori
         </em>
         in MALToma is remission of the tumor following eradication of
         <em>
          H. pylori
         </em>
         with antibiotic therapy [
         <a href="#rid96">
          96-103
         </a>
         ]. The role of
         <em>
          H. pylori
         </em>
         treatment in the management of gastric lymphoma is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/4710.html" rel="external">
          "Treatment of extranodal marginal zone lymphoma of mucosa associated lymphoid tissue (MALT lymphoma)", section on 'Stage I or II H. pylori positive'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          COLON CANCER
         </span>
         <span class="headingEndMark">
          —
         </span>
         An association between
         <em>
          H. pylori
         </em>
         infection and colorectal polyps and colorectal cancer has been described but remains controversial [
         <a href="#rid104">
          104-115
         </a>
         ].
        </p>
        <p>
         The biologic basis for such an association is uncertain. One possibility is elevated serum gastrin levels in patients with
         <em>
          H. pylori
         </em>
         infection [
         <a href="#rid105">
          105
         </a>
         ]. Gastrin receptors have been identified on a variety of colon cancer cell lines, and endogenous serum gastrin levels have been correlated with the risk of colonic neoplasms. However, studies have not found an association of serum gastrin levels with an increased risk for colonic neoplasia [
         <a href="#rid111">
          111,114
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2551.html" rel="external">
          "Physiology of gastrin"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h1">
          PANCREATIC CANCER
         </span>
         <span class="headingEndMark">
          —
         </span>
         An association between
         <em>
          H. pylori
         </em>
         infection and pancreatic cancer has been reported [
         <a href="#rid116">
          116-120
         </a>
         ]. In a meta-analysis that included 1083 patents with pancreatic cancer and 1950 controls, infection with
         <em>
          H. pylori
         </em>
         was associated with an increased risk of pancreatic cancer (OR 1.47, 95% CI 1.2-1.8) [
         <a href="#rid121">
          121
         </a>
         ]. On subgroup analysis, CagA positive
         <em>
          H. pylori
         </em>
         strains were not associated with an increased risk of pancreatic cancer. Another report found an association between colonization with non-CagA
         <em>
          H. pylori
         </em>
         strains and pancreatic cancer in patients with non-O blood types; no association was found in patients with non-O blood types infected with CagA positive
         <em>
          H. pylori
         </em>
         [
         <a href="#rid118">
          118
         </a>
         ]. (See
         <a class="local">
          'H. pylori strain differences'
         </a>
         above.)
        </p>
        <p>
         A possible mechanism proposed for the association of pancreatic cancer and
         <em>
          H. pylori
         </em>
         is the link between pancreatic cancer and chronic hyperacidity [
         <a href="#rid122">
          122
         </a>
         ] (see
         <a class="local">
          'H. pylori strain differences'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/2480.html" rel="external">
          "Epidemiology and nonfamilial risk factors for exocrine pancreatic cancer"
         </a>
         ). Additional studies are needed to confirm the association of pancreatic cancer and
         <em>
          H. pylori
         </em>
         infection and also to better support the putative role of hyperacidity.
        </p>
        <p class="headingAnchor" id="H1255753091">
         <span class="h1">
          HEPATOBILIARY CANCER
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several studies report an association between biliary tract carcinoma and infection with
         <em>
          H. pylori
         </em>
         [
         <a href="#rid123">
          123-127
         </a>
         ]. Although a cause and effect relationship has not been proven, some have suggested that
         <em>
          H. pylori
         </em>
         may be involved in the pathogenesis of biliary neoplasms through enhanced biliary cell inflammation and proliferation [
         <a href="#rid126">
          126,128
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H9071492">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15734.html" rel="external">
          "Patient education: H. pylori infection (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/2012.html" rel="external">
          "Patient education: Helicobacter pylori infection and treatment (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Approximately 36 and 47 percent of all gastric cancers in resource-abundant and resource-limited countries, respectively, are solely attributable to
         <em>
          H. pylori
         </em>
         infection. This accounts for almost 350,000 gastric cancers annually worldwide.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Several hypotheses have been proposed to explain the role of
         <em>
          H. pylori
         </em>
         in carcinogenesis, although the exact mechanism is incompletely understood. (See
         <a class="local">
          'Role of H. pylori in carcinogenesis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiple studies have demonstrated an association between
         <em>
          H. pylori
         </em>
         infection and mucosa-associated lymphoid tissue lymphoma (MALToma). The most dramatic evidence supporting a pathogenetic role for
         <em>
          H. pylori
         </em>
         in MALToma is remission of the tumor following eradication of
         <em>
          H. pylori
         </em>
         with antibiotic therapy. (See
         <a class="local">
          'Gastric lymphoma'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1680697352">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The editorial staff at UpToDate acknowledge Sheila E Crowe, MD, FRCPC, FACP, FACG, AGAF, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265:1287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990; 62:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fuchs CS, Mayer RJ. Gastric carcinoma. N Engl J Med 1995; 333:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52:6735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siurala M, Varis K, Wiljasalo M. Studies of patients with atrophic gastritis: a 10-15-year follow-up. Scand J Gastroenterol 1966; 1:40.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972; 63:584.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watanabe T, Tada M, Nagai H, et al. Helicobacter pylori infection induces gastric cancer in mongolian gerbils. Gastroenterology 1998; 115:642.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang JQ, Sridhar S, Chen Y, Hunt RH. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology 1998; 114:1169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eslick GD, Lim LL, Byles JE, et al. Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis. Am J Gastroenterol 1999; 94:2373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Persson C, Jia Y, Pettersson H, et al. H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship? PLoS One 2011; 6:e17404.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansson LR, Engstrand L, Nyrén O, Lindgren A. Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology 1995; 109:885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parsonnet J, Vandersteen D, Goates J, et al. Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas. J Natl Cancer Inst 1991; 83:640.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guarner J, Mohar A, Parsonnet J, Halperin D. The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico. Cancer 1993; 71:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 1993; 341:1359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991; 325:1127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nomura A, Stemmermann GN, Chyou PH, et al. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med 1991; 325:1132.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forman D, Newell DG, Fullerton F, et al. Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. BMJ 1991; 302:1302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansen S, Melby KK, Aase S, et al. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study. Scand J Gastroenterol 1999; 34:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Uemura N, Okamoto S, Yamamoto S, et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345:784.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Martel C, Ferlay J, Franceschi S, et al. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 2012; 13:607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Crowe SE. Helicobacter infection, chronic inflammation, and the development of malignancy. Curr Opin Gastroenterol 2005; 21:32.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Omar EM, Carrington M, Chow WH, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology 2003; 124:1193.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garza-González E, Bosques-Padilla FJ, El-Omar E, et al. Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico. Int J Cancer 2005; 114:237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Furuta T, El-Omar EM, Xiao F, et al. Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan. Gastroenterology 2002; 123:92.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Omar EM, Carrington M, Chow WH, et al. The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer. Nature 2001; 412:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lu W, Pan K, Zhang L, et al. Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population. Carcinogenesis 2005; 26:631.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rad R, Dossumbekova A, Neu B, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004; 53:1082.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ding SZ, Minohara Y, Fan XJ, et al. Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells. Infect Immun 2007; 75:4030.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis. Am J Gastroenterol 2001; 96:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moss SF, Calam J, Agarwal B, et al. Induction of gastric epithelial apoptosis by Helicobacter pylori. Gut 1996; 38:498.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones NL, Shannon PT, Cutz E, et al. Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection. Am J Pathol 1997; 151:1695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagner S, Beil W, Westermann J, et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. Gastroenterology 1997; 113:1836.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones NL, Day AS, Jennings HA, Sherman PM. Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression. Infect Immun 1999; 67:4237.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Correa P, Miller MJ. Helicobacter pylori and gastric atrophy--cancer paradoxes. J Natl Cancer Inst 1995; 87:1731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lauwers GY, Scott GV, Hendricks J. Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia. Cancer 1994; 73:2900.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Varro A, Noble PJ, Pritchard DM, et al. Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-kappaB and RhoA: implications for invasion and apoptosis. Cancer Res 2004; 64:1695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peek RM Jr, Moss SF, Tham KT, et al. Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997; 89:863.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raju D, Hussey S, Ang M, et al. Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 2012; 142:1160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Müller A. Multistep activation of the Helicobacter pylori effector CagA. J Clin Invest 2012; 122:1192.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Houghton J, Stoicov C, Nomura S, et al. Gastric cancer originating from bone marrow-derived cells. Science 2004; 306:1568.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsugane S, Tei Y, Takahashi T, et al. Salty food intake and risk of Helicobacter pylori infection. Jpn J Cancer Res 1994; 85:474.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fox JG, Dangler CA, Taylor NS, et al. High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice. Cancer Res 1999; 59:4823.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee SA, Kang D, Shim KN, et al. Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer. J Epidemiol 2003; 13:162.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Machida-Montani A, Sasazuki S, Inoue M, et al. Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan. Gastric Cancer 2004; 7:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nozaki K, Shimizu N, Inada K, et al. Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils. Jpn J Cancer Res 2002; 93:1083.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu LZ, Gao HJ, Bai JF, et al. Expression of COX-2 proteins in gastric mucosal lesions. World J Gastroenterol 2004; 10:292.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Rees BP, Saukkonen K, Ristimäki A, et al. Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J Pathol 2002; 196:171.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lim HY, Joo HJ, Choi JH, et al. Increased expression of cyclooxygenase-2 protein in human gastric carcinoma. Clin Cancer Res 2000; 6:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaise M, Miwa J, Suzuki N, et al. Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma. Eur J Gastroenterol Hepatol 2007; 19:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Toyoda T, Tsukamoto T, Hirano N, et al. Synergistic upregulation of inducible nitric oxide synthase and cyclooxygenase-2 in gastric mucosa of Mongolian gerbils by a high-salt diet and Helicobacter pylori infection. Histol Histopathol 2008; 23:593.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           González CA, López-Carrillo L. Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis. Scand J Gastroenterol 2010; 45:6.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li Z, Ying X, Shan F, Ji J. The association of garlic with Helicobacter pylori infection and gastric cancer risk: A systematic review and meta-analysis. Helicobacter 2018; 23:e12532.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kwon HJ, Won YS, Nam KT, et al. Vitamin D₃ upregulated protein 1 deficiency promotes N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric carcinogenesis in mice. Gut 2012; 61:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobala GM, Schorah CJ, Sanderson M, et al. Ascorbic acid in the human stomach. Gastroenterology 1989; 97:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Plasma vitamin concentrations in patients with intestinal metaplasia and in controls. UK Subgroup of the ECP-EURONUT-IM Study Group. Eur J Cancer Prev 1992; 1:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           You WC, Zhang L, Gail MH, et al. Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000; 92:1607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr 1991; 53:270S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feiz HR, Mobarhan S. Does vitamin C intake slow the progression of gastric cancer in Helicobacter pylori-infected populations? Nutr Rev 2002; 60:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ikeda F, Doi Y, Yonemoto K, et al. Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study. Gastroenterology 2009; 136:1234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cho Y, Lee DH, Oh HS, et al. Higher prevalence of obesity in gastric cardia adenocarcinoma compared to gastric non-cardia adenocarcinoma. Dig Dis Sci 2012; 57:2687.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang P, Zhou Y, Chen B, et al. Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies. Eur J Cancer 2009; 45:2867.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sierra R, Muñoz N, Peña AS, et al. Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer. Cancer Epidemiol Biomarkers Prev 1992; 1:449.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hansson LE, Nyrén O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med 1996; 335:242.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsugane S, Kabuto M, Imai H, et al. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993; 4:297.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Azuma T, Ito S, Sato F, et al. The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection. Cancer 1998; 82:1013.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lu H, Hsu PI, Graham DY, Yamaoka Y. Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology 2005; 128:833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rood JC, Ruiz B, Fontham ET, et al. Helicobacter pylori-associated gastritis and the ascorbic acid concentration in gastric juice. Nutr Cancer 1994; 22:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           La Vecchia C, Negri E, Franceschi S, Gentile A. Family history and the risk of stomach and colorectal cancer. Cancer 1992; 70:50.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inoue M, Tajima K, Yamamura Y, et al. Family history and subsite of gastric cancer: data from a case-referent study in Japan. Int J Cancer 1998; 76:801.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brenner H, Arndt V, Stürmer T, et al. Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma. Cancer 2000; 88:274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           El-Omar EM, Oien K, Murray LS, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000; 118:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar S, Metz DC, Ellenberg S, et al. Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study. Gastroenterology 2020; 158:527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee YC, Chiang TH, Chou CK, et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology 2016; 150:1113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li D, Jiang SF, Lei NY, et al. Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States. Gastroenterology 2023; 165:391.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parsonnet J, Harris RA, Hack HM, Owens DK. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials. Lancet 1996; 348:150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fendrick AM, Chernew ME, Hirth RA, et al. Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer. Arch Intern Med 1999; 159:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Talley NJ, Fock KM, Moayyedi P. Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer. Am J Gastroenterol 2008; 103:510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61:646.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972; 29:252.
          </a>
         </li>
         <li class="breakAll">
          Isaacson PG. Gastrointestinal lymphomas and lymphoid hyperplasias. In: Neoplastic Haematolpathology, Knowles DM (Ed), Williams &amp; Wilkins, Baltimore 1992. p.953.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Clark EA, Ledbetter JA. How B and T cells talk to each other. Nature 1994; 367:425.
          </a>
         </li>
         <li class="breakAll">
          Lydyard P, Grossi C. Secondary lymphoid organs and tissues. In: Immunology, 4th ed, Roitt I, Brostoff J, Male D (Eds), Mosby, London 1996. p.31.
         </li>
         <li>
          <a class="nounderline abstract_t">
           D'Elios MM, Amedei A, Manghetti M, et al. Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. Gastroenterology 1999; 117:1105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zucca E, Bertoni F, Roggero E, et al. Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach. N Engl J Med 1998; 338:804.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wotherspoon AC, Ortiz-Hidalgo C, Falzon MR, Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338:1175.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330:1267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eck M, Schmausser B, Haas R, et al. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997; 112:1482.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang CS, Chen LT, Yang JC, et al. Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomach. Gastroenterology 1999; 117:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazzucchelli L, Blaser A, Kappeler A, et al. BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 1999; 104:R49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stolte M, Kroher G, Meining A, et al. A comparison of Helicobacter pylori and H. heilmannii gastritis. A matched control study involving 404 patients. Scand J Gastroenterol 1997; 32:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin WC, Tsai HF, Kuo SH, et al. Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma. Cancer Res 2010; 70:5740.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morgner A, Lehn N, Andersen LP, et al. Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection. Gastroenterology 2000; 118:821.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993; 342:575.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Savio A, Franzin G, Wotherspoon AC, et al. Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both? Blood 1996; 87:1255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weber DM, Dimopoulos MA, Anandu DP, et al. Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori. Gastroenterology 1994; 107:1835.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roggero E, Zucca E, Pinotti G, et al. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995; 122:767.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carlson SJ, Yokoo H, Vanagunas A. Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori. JAMA 1996; 275:937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinbach G, Ford R, Glober G, et al. Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med 1999; 131:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fischbach W, Goebeler-Kolve ME, Dragosics B, et al. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series. Gut 2004; 53:34.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Okame M, Takaya S, Sato H, et al. Complete regression of early-stage gastric diffuse large B-cell lymphoma in an HIV-1-infected patient following Helicobacter pylori eradication therapy. Clin Infect Dis 2014; 58:1490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Breuer-Katschinski B, Nemes K, Marr A, et al. Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group. Digestion 1999; 60:210.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aydin A, Karasu Z, Zeytinoglu A, et al. Colorectal adenomateous polyps and Helicobacter pylori infection. Am J Gastroenterol 1999; 94:1121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meucci G, Tatarella M, Vecchi M, et al. High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas. J Clin Gastroenterol 1997; 25:605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shmuely H, Passaro D, Figer A, et al. Relationship between Helicobacter pylori CagA status and colorectal cancer. Am J Gastroenterol 2001; 96:3406.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 2013; 108:208.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moss SF, Neugut AI, Garbowski GC, et al. Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association. J Natl Cancer Inst 1995; 87:762.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siddheshwar RK, Muhammad KB, Gray JC, Kelly SB. Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma. Am J Gastroenterol 2001; 96:84.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Robertson DJ, Sandler RS, Ahnen DJ, et al. Gastrin, Helicobacter pylori, and colorectal adenomas. Clin Gastroenterol Hepatol 2009; 7:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Y, Hoffmeister M, Weck MN, et al. Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol 2012; 175:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hong SN, Lee SM, Kim JH, et al. Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis. Dig Dis Sci 2012; 57:2184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Selgrad M, Bornschein J, Kandulski A, et al. Helicobacter pylori but not gastrin is associated with the development of colonic neoplasms. Int J Cancer 2014; 135:1127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Epplein M, Pawlita M, Michel A, et al. Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2013; 22:1964.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, et al. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 2001; 93:937.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Raderer M, Wrba F, Kornek G, et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology 1998; 55:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Risch HA, Yu H, Lu L, Kidd MS. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 2010; 102:502.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trikudanathan G, Philip A, Dasanu CA, Baker WL. Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP 2011; 12:26.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yu G, Murphy G, Michel A, et al. Seropositivity to Helicobacter pylori and risk of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2013; 22:2416.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Xiao M, Wang Y, Gao Y. Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis. PLoS One 2013; 8:e75559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Risch HA. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 2003; 95:948.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chang JS, Tsai CR, Chen LT. Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study. PLoS One 2013; 8:e69981.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bulajic M, Maisonneuve P, Schneider-Brachert W, et al. Helicobacter pylori and the risk of benign and malignant biliary tract disease. Cancer 2002; 95:1946.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pandey M, Shukla M. Helicobacter species are associated with possible increase in risk of hepatobiliary tract cancers. Surg Oncol 2009; 18:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boonyanugomol W, Chomvarin C, Sripa B, et al. Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation. HPB (Oxford) 2012; 14:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Murphy G, Michel A, Taylor PR, et al. Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study. Hepatology 2014; 60:1963.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Segura-López FK, Güitrón-Cantú A, Torres J. Association between Helicobacter spp. infections and hepatobiliary malignancies: a review. World J Gastroenterol 2015; 21:1414.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2514 Version 35.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7715068" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21296855" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Global cancer statistics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1995976" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Rising incidence of adenocarcinoma of the esophagus and gastric cardia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2206952" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7776992" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Gastric carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1458460" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5914451" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Studies of patients with atrophic gastritis: a 10-15-year follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5077145" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9721161" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Helicobacter pylori infection induces gastric cancer in mongolian gerbils.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9609753" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10483994" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21399687" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : H. pylori seropositivity before age 40 and subsequent risk of stomach cancer: a glimpse of the true relationship?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7657118" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Prevalence of Helicobacter pylori infection in subtypes of gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2023282" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Helicobacter pylori infection in intestinal- and diffuse-type gastric adenocarcinomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8422620" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : The association of Helicobacter pylori with gastric cancer and preneoplastic gastric lesions in Chiapas, Mexico.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8098787" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1891020" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Helicobacter pylori infection and the risk of gastric carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1891021" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2059685" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10365894" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11556297" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Helicobacter pylori infection and the development of gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22575588" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15687882" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Helicobacter infection, chronic inflammation, and the development of malignancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10746728" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Interleukin-1 polymorphisms associated with increased risk of gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12730860" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Increased risk of noncardia gastric cancer associated with proinflammatory cytokine gene polymorphisms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15540224" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Role of the polymorphic IL-1B, IL-1RN and TNF-A genes in distal gastric cancer in Mexico.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12105837" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Interleukin 1beta polymorphisms increase risk of hypochlorhydria and atrophic gastritis and reduce risk of duodenal ulcer recurrence in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11808612" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : The role of interleukin-1 polymorphisms in the pathogenesis of gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15579481" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Genetic polymorphisms of interleukin (IL)-1B, IL-1RN, IL-8, IL-10 and tumor necrosis factor {alpha} and risk of gastric cancer in a Chinese population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15247172" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17562777" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Helicobacter pylori infection induces oxidative stress and programmed cell death in human gastric epithelial cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11197247" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Apoptosis in gastric epithelium induced by Helicobacter pylori infection: implications in gastric carcinogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8707076" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Induction of gastric epithelial apoptosis by Helicobacter pylori.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9403720" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Increase in proliferation and apoptosis of gastric epithelial cells early in the natural history of Helicobacter pylori infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9394723" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10417197" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Helicobacter pylori induces gastric epithelial cell apoptosis in association with increased Fas receptor expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7473824" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Helicobacter pylori and gastric atrophy--cancer paradoxes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8199986" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Immunohistochemical evidence of aberrant bcl-2 protein expression in gastric epithelial dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14996729" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Helicobacter pylori induces plasminogen activator inhibitor 2 in gastric epithelial cells through nuclear factor-kappaB and RhoA: implications for invasion and apoptosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9196252" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Helicobacter pylori cagA+ strains and dissociation of gastric epithelial cell proliferation from apoptosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22333951" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22378039" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Multistep activation of the Helicobacter pylori effector CagA.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15567866" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Gastric cancer originating from bone marrow-derived cells.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8014104" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Salty food intake and risk of Helicobacter pylori infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10519391" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : High-salt diet induces gastric epithelial hyperplasia and parietal cell loss, and enhances Helicobacter pylori colonization in C57BL/6 mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12749604" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Effect of diet and Helicobacter pylori infection to the risk of early gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15052440" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Association of Helicobacter pylori infection and environmental factors in non-cardia gastric cancer in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12417037" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Synergistic promoting effects of Helicobacter pylori infection and high-salt diet on gastric carcinogenesis in Mongolian gerbils.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14716842" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Expression of COX-2 proteins in gastric mucosal lesions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11793368" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Cyclooxygenase-2 expression during carcinogenesis in the human stomach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10690533" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Increased expression of cyclooxygenase-2 protein in human gastric carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17272999" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Inducible nitric oxide synthase gene promoter polymorphism is associated with increased gastric mRNA expression of inducible nitric oxide synthase and increased risk of gastric carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18283644" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Synergistic upregulation of inducible nitric oxide synthase and cyclooxygenase-2 in gastric mucosa of Mongolian gerbils by a high-salt diet and Helicobacter pylori infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20030576" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30155945" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : The association of garlic with Helicobacter pylori infection and gastric cancer risk: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21917648" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Vitamin D₃upregulated protein 1 deficiency promotes N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric carcinogenesis in mice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2744355" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Ascorbic acid in the human stomach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1463980" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Plasma vitamin concentrations in patients with intestinal metaplasia and in controls. UK Subgroup of the ECP-EURONUT-IM Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11018097" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1985398" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Vitamin C and cancer prevention: the epidemiologic evidence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11843002" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Does vitamin C intake slow the progression of gastric cancer in Helicobacter pylori-infected populations?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19236964" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Hyperglycemia increases risk of gastric cancer posed by Helicobacter pylori infection: a population-based cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22484493" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Higher prevalence of obesity in gastric cardia adenocarcinoma compared to gastric non-cardia adenocarcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19427197" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Overweight, obesity and gastric cancer risk: results from a meta-analysis of cohort studies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1302556" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Antibodies to Helicobacter pylori and pepsinogen levels in children from Costa Rica: comparison of two areas with different risks for stomach cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8657240" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The risk of stomach cancer in patients with gastric or duodenal ulcer disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8347778" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9506344" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : The role of the HLA-DQA1 gene in resistance to atrophic gastritis and gastric adenocarcinoma induced by Helicobacter pylori infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15825067" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Duodenal ulcer promoting gene of Helicobacter pylori.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11304911" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Helicobacter pylori-associated gastritis and the ascorbic acid concentration in gastric juice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1606546" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Family history and the risk of stomach and colorectal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9626344" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Family history and subsite of gastric cancer: data from a case-referent study in Japan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10640957" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Individual and joint contribution of family history and Helicobacter pylori infection to the risk of gastric carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10611150" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31654635" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Risk Factors and Incidence of Gastric Cancer After Detection of Helicobacter pylori Infection: A Large Cohort Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26836587" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37142201" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Effect of Helicobacter pylori Eradication Therapy on the Incidence of Noncardia Gastric Adenocarcinoma in a Large Diverse Population in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8684154" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: a mandate for clinical trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9927096" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Clinical and economic effects of population-based Helicobacter pylori screening to prevent gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18341483" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Gastric Cancer Consensus conference recommends Helicobacter pylori screening and treatment in asymptomatic persons from high-risk populations to prevent gastric cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22491499" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5007387" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Occurrence and prognosis of extranodal lymphomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5007387" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Occurrence and prognosis of extranodal lymphomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8107800" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : How B and T cells talk to each other.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8107800" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : How B and T cells talk to each other.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10535873" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9504941" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Molecular analysis of the progression from Helicobacter pylori-associated chronic gastritis to mucosa-associated lymphoid-tissue lymphoma of the stomach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1682595" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8145781" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Helicobacter pylori infection and gastric lymphoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9136825" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10381913" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Isolation of a Helicobacter pylori protein, FldA, associated with mucosa-associated lymphoid tissue lymphoma of the stomach.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10562310" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9018763" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : A comparison of Helicobacter pylori and H. heilmannii gastritis. A matched control study involving 404 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20587516" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Translocation of Helicobacter pylori CagA into Human B lymphocytes, the origin of mucosa-associated lymphoid tissue lymphoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10784580" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Helicobacter heilmannii-associated primary gastric low-grade MALT lymphoma: complete remission after curing the infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8102719" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8608213" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Diagnosis and posttreatment follow-up of Helicobacter pylori-positive gastric lymphoma of mucosa-associated lymphoid tissue: histology, polymerase chain reaction, or both?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7958698" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Regression of gastric lymphoma of mucosa-associated lymphoid tissue with antibiotic therapy for Helicobacter pylori.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7717599" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8598622" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Progression of gastritis to monoclonal B-cell lymphoma with resolution and recurrence following eradication of Helicobacter pylori.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10419446" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14684573" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24585569" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Complete regression of early-stage gastric diffuse large B-cell lymphoma in an HIV-1-infected patient following Helicobacter pylori eradication therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10343134" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Helicobacter pylori and the risk of colonic adenomas. Colorectal Adenoma Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10201512" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Colorectal adenomateous polyps and Helicobacter pylori infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9451672" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : High prevalence of Helicobacter pylori infection in patients with colonic adenomas and carcinomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11774957" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Relationship between Helicobacter pylori CagA status and colorectal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23208272" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Helicobacter pylori is a risk factor for colonic neoplasms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7563155" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Helicobacter pylori seroprevalence and colorectal neoplasia: evidence against an association.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11197293" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Seroprevalence of Helicobacter pylori in patients with colorectal polyps and colorectal carcinoma.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18929688" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Gastrin, Helicobacter pylori, and colorectal adenomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22294430" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22669208" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24496701" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Helicobacter pylori but not gastrin is associated with the development of colonic neoplasms.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24045925" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Helicobacter pylori protein-specific antibodies and risk of colorectal cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11416115" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Helicobacter pylori seropositivity as a risk factor for pancreatic cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9428370" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Association between Helicobacter pylori infection and pancreatic cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20181960" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21206097" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24089457" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Seropositivity to Helicobacter pylori and risk of pancreatic cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24086571" id="rid120" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          121 : Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12837831" id="rid121" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          122 : Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23894567" id="rid122" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          123 : Medical risk factors associated with cholangiocarcinoma in Taiwan: a population-based case-control study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12404289" id="rid123" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          124 : Helicobacter pylori and the risk of benign and malignant biliary tract disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18715780" id="rid124" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          125 : Helicobacter species are associated with possible increase in risk of hepatobiliary tract cancers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22321036" id="rid125" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          126 : Helicobacter pylori in Thai patients with cholangiocarcinoma and its association with biliary inflammation and proliferation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24797247" id="rid126" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          127 : Association of seropositivity to Helicobacter species and biliary tract cancer in the ATBC study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25663761" id="rid127" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          128 : Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
